Loving-kindness Meditation for Posttraumatic Stress Disorder (PTSD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
David Kearney, Seattle Institute for Biomedical and Clinical Research
ClinicalTrials.gov Identifier:
NCT01607632
First received: May 23, 2012
Last updated: May 24, 2012
Last verified: May 2012
  Purpose

A before and after study of veterans who took part in a 12-week loving-kindness meditation course as an adjunct to their usual care for posttraumatic stress disorder.


Condition Intervention
Posttraumatic Stress Disorder
Behavioral: loving-kindness meditation

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Open Pilot Study of Loving-Kindness Meditation for PTSD

Resource links provided by NLM:


Further study details as provided by Seattle Institute for Biomedical and Clinical Research:

Primary Outcome Measures:
  • change in PTSD symptoms [ Time Frame: baseline, post-intervention, 3-month follow-up ] [ Designated as safety issue: Yes ]
    The PTSD symptom-scale interview was performed

  • change in depressive symptoms [ Time Frame: baseline, post-intervention, 3-month follow-up ] [ Designated as safety issue: No ]
    The PROMIS measure for depression was administered


Enrollment: 42
Study Start Date: January 2010
Study Completion Date: June 2011
Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: loving-kindness meditation Behavioral: loving-kindness meditation
A 12-week duration, 90 minute per session loving-kindness meditation course

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • posttraumatic stress disorder

Exclusion Criteria:

  • psychosis
  • borderline personality disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01607632

Locations
United States, Washington
VA Puget Sound
Seattle, Washington, United States, 98108
Sponsors and Collaborators
Seattle Institute for Biomedical and Clinical Research
Investigators
Principal Investigator: David Kearney, MD VA Puget Sound
  More Information

No publications provided

Responsible Party: David Kearney, Staff Physician, Seattle Institute for Biomedical and Clinical Research
ClinicalTrials.gov Identifier: NCT01607632     History of Changes
Other Study ID Numbers: 00173
Study First Received: May 23, 2012
Last Updated: May 24, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Seattle Institute for Biomedical and Clinical Research:
posttraumatic stress
depression

Additional relevant MeSH terms:
Stress Disorders, Traumatic
Stress Disorders, Post-Traumatic
Disease
Anxiety Disorders
Mental Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on September 22, 2014